Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Has results × Mycoses × Clear all

Status

Sponsor Class

Study Type

Interventional 7 Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 103 Neoplasms 63 Carcinoma, Non-Small-Cell Lung 32 Colorectal Neoplasms 31 Carcinoma, Renal Cell 31 Prostatic Neoplasms 30 Lung Neoplasms 23 Melanoma 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Multiple Myeloma 12 Ovarian Neoplasms 11 Lymphoma, Follicular 11 Colonic Neoplasms 11 Urinary Bladder Neoplasms 10 Neoplasm Metastasis 10 Hematologic Neoplasms 10 Arthritis, Rheumatoid 9 Stomach Neoplasms 8 Recurrence 8 Rectal Neoplasms 8 Papillomavirus Infections 8 Lymphoma 8 Kidney Neoplasms 8 Pancreatic Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Leukemia, Myeloid, Acute 7 Carcinoma, Hepatocellular 7 Neoplasms, Plasma Cell 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Head and Neck Neoplasms 6

Interventions

Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01254318 2016-11-02

TRAFIC

Merck Sharp & Dohme LLC

130 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Mycoses, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡